The influence of exo-enzyme S and proteases on endogenous Pseudomonas aeruginosa bacteraemia in mice

References

1. Bryan C. S., Reynolds K. L., Brenner E. R. Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis 1983; 5:629–638
   [Google Scholar]
2. Dick J. D., Shull V., Karp J. E., Valentine J. Bacterial and host factors affecting Pseudomonas aeruginosa colonization versus bacteremia in granulocytopenic patients. Eur J Cancer Clin Oncol 1988; 24: Suppl 1S47–S54
   [Google Scholar]
3. Young L. S., Stevens P., Kaijser B. Gram-negative pathogens in septicaemic infections. Scand J Infect Dis 1982 Suppl 3178–94
   [Google Scholar]
4. Liu P. V. Extracellular toxins of Pseudomonas aeruginosa. J Infect Dis 1974; 130: Suppl: S 94–99
   [Google Scholar]
5. Nicas T. I., Iglewski B. H. The contribution of exoproducts to virulence of Pseudomonas aeruginosa. Can J Microbiol 1985; 31:387–392
   [Google Scholar]
6. Hirakata Y., Furuya N., Tateda K., Kaku M., Yamaguchi K. In vivo production of exot/oxin A and its role in endogenous Pseudomonas aeruginosa septicemia in mice. Infect Immun 1993; 61:2468–2473
   [Google Scholar]
7. Cryz S. J., Friedman R. L., Iglewski B. H. Isolation and charac terization of a Pseudomonas aeruginosa mutant producing nontoxic, immunologically crossreactive toxin A protein. Proc Natl Acad Sci USA 1980; 77:7199–7203
   [Google Scholar]
8. Furuya N., Hirakata Y., Tomono K. Mortality rates amongst mice with endogenous septicaemia due to Pseudomonas aeruginosa isolates from various clinical sources. J Med Microbiol 1993; 39:141–146
   [Google Scholar]
9. Holloway B. W., Krishnapillai V., Morgan A. F. Chromosomal genetics of Pseudomonas. Microbiol Rev 1979; 43:73–102
   [Google Scholar]
10. Ohman D. E., Cryz S. J., Iglewski B. H. Isolation and charac terization of Pseudomonas aeruginosa PAO mutant that produces altered elastase. J Bacteriol 1980; 142:836–842
    [Google Scholar]
11. Iglewski B. H., Sadoff J., Bjorn M. J., Maxwell E. S. Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyl-transferase distinct from toxin A. Proc Natl Acad Sci USA 1978; 75:3211–3215
    [Google Scholar]
12. Nicas T. I., Iglewski B. H. Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S. Infect Immun 1984; 45:470–474
    [Google Scholar]
13. Ohman D. E., Burns R. P., Iglewski B. H. Corneal infections in mice with toxin A and elastase mutants of Pseudomonas aeruginosa. J Infect Dis 1980; 142:547–555
    [Google Scholar]
14. Woods D. E., Que J. U. Purification of Pseudomonas aeruginosa exoenzyme S. Infect Immun 1987; 55:579–586
    [Google Scholar]
15. Woods D. E., Sokol P. A. Use of transposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Pseudomonas aeruginosa. Eur J Clin Microbiol 1985; 4:163–169
    [Google Scholar]
16. Wretlind B., Sjӧberg L., Wadstrӧm T. Protease-deficient mutants of Pseudomonas aeruginosa: pleiotropic changes in activity of other extracellular enzymes. J Gen Microbiol 1977; 103:329–336
    [Google Scholar]
17. Hirakata Y., Kaku M., Tomono K. Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice. Antimicrob Agents Chemother 1992; 36:1198–1203
    [Google Scholar]
18. Woods D. E., Schaffer M. S., Rabin H. R., Campbell G. D., Sokol P. A. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J Clin Microbiol 1986; 24:260–264
    [Google Scholar]
19. Morihara K., Tsuzuki H., Oda K. Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma alpha-proteinase inhibitor. Infect Immun 1979; 24:188–193
    [Google Scholar]
20. Sokol P. A., Iglewski B. H., Hager T. A. Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa. Infect Immun 1981; 34:147–153
    [Google Scholar]
21. Hirakata Y., Tomono K., Tateda K. Role of bacterial association with Kupffer cells in occurrence of endogenous systemic bacteremia. Infect Immun 1991; 59:289–294
    [Google Scholar]